Serum cytokine levels in patients with acute brucellosis and their relation to the traditional inflammatory markers

dc.contributor.authorDemirdag, K
dc.contributor.authorOzden, M
dc.contributor.authorKalkan, A
dc.contributor.authorGodekmerdan, A
dc.contributor.authorKilic, SS
dc.date.accessioned2026-08-12T16:34:17Z
dc.date.issued2003
dc.departmentFırat Üniversitesi
dc.description.abstractThe number of clinical studies on gamma interferon (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha) and interleukin-4 (IL-4) in human brucellosis is limited. The present study was focused on IFN-gamma, TNF-alpha and IL-4 levels in acute brucellosis cases, in the acute phase and at the end of the treatment. The relation of these cytokines to traditional inflammation markers was also investigated. The study included 27 cases of acute brucellosis and 20 healthy volunteers who had no complaints. It was found that mean IFN-gamma and TNF-alpha levels, CRP (C-reactive protein) levels and ESR (erythrocyte sedimentation rate) values were significantly higher in acute brucellosis cases as compared to post-treatment values and values measured in the control group. In addition, IFN-gamma and TNF-alpha levels measured in the acute phase correlated with the increase in CRP levels and ESR values. Our results confirmed that IFN-gamma and TNF-alpha are involved in the pathophysiology of brucellosis and are closely related to the inflammatory activation of the disease. In view of the present findings, it is suggested that IFN-gamma and TNFalpha may be used for monitoring brucellosis. (C) 2003 Federation of European Microbiological Societies. Published by Elsevier B.V.. All rights reserved.
dc.identifier.doi10.1016/S0928-8244(03)00207-4
dc.identifier.endpage153
dc.identifier.issn0928-8244
dc.identifier.issn1574-695X
dc.identifier.issue2
dc.identifier.pmid14625098
dc.identifier.scopus2-s2.0-0242643583
dc.identifier.scopusqualityN/A
dc.identifier.startpage149
dc.identifier.urihttps://doi.org/10.1016/S0928-8244(03)00207-4
dc.identifier.urihttps://hdl.handle.net/11508/44386
dc.identifier.volume39
dc.identifier.wosWOS:000186920400008
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofFems Immunology and Medical Microbiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectbrucellosis
dc.subjectcytokine
dc.subjectinflammatory marker
dc.subjecttreatment
dc.titleSerum cytokine levels in patients with acute brucellosis and their relation to the traditional inflammatory markers
dc.typeArticle

Dosyalar